Back

Prognostic associations of major bleeding in anticoagulated patients with atrial fibrillation after TAVI: a post hoc analysis of the ENVISAGE-TAVI AF trial

28 August 2026 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation: real-world outcomes and risk Stroke in Atrial Fibrillation ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor George Dangas

Mount Sinai Medical Center, New York (United States of America)

5 More presentations in this session

Presentation thumbnail
Impact of frailty on in-hospital and long-term outcomes after atrial fibrillation ablation in patients aged ≥75 years
Doctor H. Altamimi (Concord West, AU)
Abstract Slides Video
Presentation thumbnail
Long-term ozone exposure and risk of cerebrovascular and cardiovascular events in patients with atrial fibrillation: a nationwide cohort study
Doctor C. Wang (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes following atrial fibrillation diagnosis in routine practice: a nationwide cohort study in Sweden
Professor J. Engdahl (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
On-label versus off-label direct oral anticoagulant dosing patterns and associated outcomes in atrial fibrillation: a real-world cohort analysis
Professor G. Patti (Novara, IT)
Abstract Slides Video
Presentation thumbnail
Clinical impact of atrial fibrillation on cardiac parameters and long-term outcomes in patients with transthyretin amyloid cardiomyopathy in the era of disease-modifying therapy
Doctor S. Yamauchi (Okayama, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation: real-world outcomes and risk

The Event

Event poster

ESC Congress 2026

28 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Session
What you need to know about antithrombotic therapy in patients after TAVI
28 August 2022
thumbnail
Congress Presentation
Impact of left atrial appendage closure on events after severe gastrointestinal bleeding in anticoagulated patients with atrial fibrillation: real life data from the PERSEO registry.
1 September 2025
thumbnail
Congress Presentation
Predictors and impact of major bleeding events in atrial fibrillation patients: a multistate model analysis form two large observational registries
29 August 2025
thumbnail
Congress Presentation
Incidence and predictors of major bleeding among patients receiving apixaban or aspirin for subclinical atrial fibrillation: insights from the ARTESiA sub-analysis
31 March 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources